serum
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
Circulating circMBOAT2 distinguishes HCM/HNCM/HOCM patients from controls with reported ROC discrimination (AUC range for circRNAs).
Serum circMBOAT2 is down-regulated in HCM and provides diagnostic discrimination between HCM (including HNCM/HOCM) and controls based on ROC analyses, supporting its potential as a blood-based biomarker.
0.459
Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy.
combined biological and clinical study